Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolin Ertl

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Innere Medizin (Heidelberg, Germany)|August 8, 2024
[Side effects of Immune Checkpoint Inhibitors : Diagnostics and Management-an Update]Carolin Ertl, Dirk Tomsitz, Najib Ben Khaled
The Oncologist|September 10, 2025
Real-world management and outcomes of immune-related adverse events in German cancer care: A multicenter analysis using the SERIO registryCarolin Ertl, Dirk Tomsitz, Filippo Rizzo, et al.
Frontiers in Cellular Neuroscience|March 7, 2022
Cuprizone Intoxication Results in Myelin Vacuole FormationSarah Joost, Felix Schweiger, Friederike Pfeiffer, et al.
Dermatology and Therapy|March 24, 2026
A Retrospective Real-World Comparison of Topical Delgocitinib and Localized Cream Psoralen-Ultraviolet A in Chronic Hand EczemaStefan Weißinger, Eva Oppel, Nils Kurzen, et al.
The Oncologist|August 19, 2025
Acquired Hemophilia due to Immune Checkpoint Inhibitors: A Case Series Introducing Emicizumab TreatmentLouis Wolff, Carolin Ertl, Lucie Heinzerling, et al.
Journal for Immunotherapy of Cancer|June 12, 2026
Extracorporeal photopheresis versus systemic immunosuppression for treatment of immune-related adverse events: clinical outcomes from the prospective two-arm PRIA studyLisa Wein, Carolin Ertl, Theresa Ruf, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2024
Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitorsTheresa Ruf, Rafaela Kramer, Andrea Forschner, et al.
Frontiers in Cardiovascular Medicine|June 25, 2024
Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicityYing Wang, Carolin Ertl, Christina Schmitt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2024
The side effect registry immuno-oncology (SERIO) - A tool for systematic analysis of immunotherapy-induced side effectsCarolin Ertl, Theresa Ruf, Dirk Mentzer, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Innere Medizin (Heidelberg, Germany)|August 8, 2024
[Side effects of Immune Checkpoint Inhibitors : Diagnostics and Management-an Update]Carolin Ertl, Dirk Tomsitz, Najib Ben Khaled
The Oncologist|September 10, 2025
Real-world management and outcomes of immune-related adverse events in German cancer care: A multicenter analysis using the SERIO registryCarolin Ertl, Dirk Tomsitz, Filippo Rizzo, et al.
Frontiers in Cellular Neuroscience|March 7, 2022
Cuprizone Intoxication Results in Myelin Vacuole FormationSarah Joost, Felix Schweiger, Friederike Pfeiffer, et al.
Dermatology and Therapy|March 24, 2026
A Retrospective Real-World Comparison of Topical Delgocitinib and Localized Cream Psoralen-Ultraviolet A in Chronic Hand EczemaStefan Weißinger, Eva Oppel, Nils Kurzen, et al.
The Oncologist|August 19, 2025
Acquired Hemophilia due to Immune Checkpoint Inhibitors: A Case Series Introducing Emicizumab TreatmentLouis Wolff, Carolin Ertl, Lucie Heinzerling, et al.
Journal for Immunotherapy of Cancer|June 12, 2026
Extracorporeal photopheresis versus systemic immunosuppression for treatment of immune-related adverse events: clinical outcomes from the prospective two-arm PRIA studyLisa Wein, Carolin Ertl, Theresa Ruf, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2024
Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitorsTheresa Ruf, Rafaela Kramer, Andrea Forschner, et al.
Frontiers in Cardiovascular Medicine|June 25, 2024
Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicityYing Wang, Carolin Ertl, Christina Schmitt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2024
The side effect registry immuno-oncology (SERIO) - A tool for systematic analysis of immunotherapy-induced side effectsCarolin Ertl, Theresa Ruf, Dirk Mentzer, et al.
Pageof 1